中华临床医师杂志(电子版)
中華臨床醫師雜誌(電子版)
중화림상의사잡지(전자판)
CHINESE JOURNAL OF CLINICIANS(ELECTRONIC VERSION)
2013年
13期
5948-5952
,共5页
王明海%洪洋%甘少磊%冯庆玲%吴俊国%钱光%耿雷%董有海
王明海%洪洋%甘少磊%馮慶玲%吳俊國%錢光%耿雷%董有海
왕명해%홍양%감소뢰%풍경령%오준국%전광%경뢰%동유해
内皮,血管%组织工程%血管化%可注射性%牵拉成骨
內皮,血管%組織工程%血管化%可註射性%牽拉成骨
내피,혈관%조직공정%혈관화%가주사성%견랍성골
Endothelium,vascular%Tissue engineering%Vascularization%Injectable%Distraction os-teogenesis
目的:将血管化可注射性纳米组织工程骨注入骨延长区,观察血管形成及骨再生的情况,揭示组织工程骨再血管化和成骨的关系。方法以可注射性纳米羟基磷灰石胶原( NHAC)/藻酸盐水凝胶为载体,复合成骨细胞和血管内皮细胞构建血管化可注射性纳米组织工程骨,将其注入肢体延长动物模型骨延长区,以空白对照组、注射单纯成骨细胞复合可注射性纳米材料组为对照,通过组织学切片、毛细血管计数、骨小梁百分比面积测定,观察血管化及骨生成情况。结果毛细血管计数显示第3周:A组4.8±9.1,B组7.4±9.2,C组10.7±8.5;第6周:A组15.1±7.2,B组19.3±15.8,C组31.5±18.2,各时段3组间均有统计学意义(P<0.05),C组血管计数值最高,血管化明显优于其他组。骨小梁百分比面积测定显示第3周:A组4.52±7.31,B组10.20±9.65, C组21.33±16.4;第6周:A组22.56±8.76, B组41.95±16.27, C组58.36±11.39,各时段3组间均有统计学意义(P<0.05),数值由高到低顺序排列为:C组>B组>A组,C组骨小梁百分比面积最大。结论血管化可注射性纳米组织工程骨应用于牵拉成骨,可促进骨延长区血管化及骨生成,优于单纯成骨细胞复合可注射性纳米材料。
目的:將血管化可註射性納米組織工程骨註入骨延長區,觀察血管形成及骨再生的情況,揭示組織工程骨再血管化和成骨的關繫。方法以可註射性納米羥基燐灰石膠原( NHAC)/藻痠鹽水凝膠為載體,複閤成骨細胞和血管內皮細胞構建血管化可註射性納米組織工程骨,將其註入肢體延長動物模型骨延長區,以空白對照組、註射單純成骨細胞複閤可註射性納米材料組為對照,通過組織學切片、毛細血管計數、骨小樑百分比麵積測定,觀察血管化及骨生成情況。結果毛細血管計數顯示第3週:A組4.8±9.1,B組7.4±9.2,C組10.7±8.5;第6週:A組15.1±7.2,B組19.3±15.8,C組31.5±18.2,各時段3組間均有統計學意義(P<0.05),C組血管計數值最高,血管化明顯優于其他組。骨小樑百分比麵積測定顯示第3週:A組4.52±7.31,B組10.20±9.65, C組21.33±16.4;第6週:A組22.56±8.76, B組41.95±16.27, C組58.36±11.39,各時段3組間均有統計學意義(P<0.05),數值由高到低順序排列為:C組>B組>A組,C組骨小樑百分比麵積最大。結論血管化可註射性納米組織工程骨應用于牽拉成骨,可促進骨延長區血管化及骨生成,優于單純成骨細胞複閤可註射性納米材料。
목적:장혈관화가주사성납미조직공정골주입골연장구,관찰혈관형성급골재생적정황,게시조직공정골재혈관화화성골적관계。방법이가주사성납미간기린회석효원( NHAC)/조산염수응효위재체,복합성골세포화혈관내피세포구건혈관화가주사성납미조직공정골,장기주입지체연장동물모형골연장구,이공백대조조、주사단순성골세포복합가주사성납미재료조위대조,통과조직학절편、모세혈관계수、골소량백분비면적측정,관찰혈관화급골생성정황。결과모세혈관계수현시제3주:A조4.8±9.1,B조7.4±9.2,C조10.7±8.5;제6주:A조15.1±7.2,B조19.3±15.8,C조31.5±18.2,각시단3조간균유통계학의의(P<0.05),C조혈관계수치최고,혈관화명현우우기타조。골소량백분비면적측정현시제3주:A조4.52±7.31,B조10.20±9.65, C조21.33±16.4;제6주:A조22.56±8.76, B조41.95±16.27, C조58.36±11.39,각시단3조간균유통계학의의(P<0.05),수치유고도저순서배렬위:C조>B조>A조,C조골소량백분비면적최대。결론혈관화가주사성납미조직공정골응용우견랍성골,가촉진골연장구혈관화급골생성,우우단순성골세포복합가주사성납미재료。
Objective To observe bone angiogenesis and regeneration and to reveal the relationship of tissue engineered bone revascularization and osteogenesis after the application of the injectable nano -vascularized tissue-engineered bone .Methods To construct vascularization injectable nano tissue engineered bone with osteoblasts and endothelial cells and apply in distraction osteogenesis .Observed the angiogenesis and osteogenesis by histological examination,capillaries count,bone trabecula area percent after the application of the injectable nano -vascularized tissue-engineered bone in group C .At the same time compared with the empty control group-group A and the simple osteoblasts composite injectable nano tissue-engineered bone group-group B.Results Capillary counting display in third weeks:group A 4.8 ±9.1 ,group B 7.4 ±9.2 ,group C 10.7 ±8.5;Capillary counting display in sixth weeks:group A 15.1 ±7.2 , group B 19.3 ±15.8 , group C 31.5 ±18.2 .Two periods of time between the 3 groups were statistically significant ( P<0.05 ) .Group C vessel count value maximum .Vascularization was superior to the other group.In third weeks,the percentage area of trabecular bone:group A 4.52 ±7.31,group B 10.20 ±9.65,group C 21.33 ±16.4;In sixth weeks, the percentage area of trabecular bone:group A 22.56 ±8.76, group B 41.95 ±16.27 ,group C 58.36 ±11.39 .Two periods of time between the 3 groups were statistically significant ( P<0.05 ) .Value from high to low order was group C to group B then to group A .Group C trabecular bone area was the largest percentage .Conclusion The injectable nano-vascularized tissue-engineered bone can accelerate the angiogenesis and osteogenesis and excelled the simple osteoblasts composite injectable nano tissue -engineered bone .